Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Merck & Co. Inc. sell Societe Generale

Start price
€111.80
11.03.24 / 50%
Target price
€95.15
11.03.25
Performance (%)
-22.27%
End price
€86.90
12.03.25
Summary
This prediction ended on 12.03.25 with a price of €86.90. The price of Merck & Co. Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -22.27%. Dividends of €2.89 are taken into consideration when calculating the performance. Societe_Generale has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Merck & Co. Inc. 1.198% 1.198% -11.518%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by Societe_Generale for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Sell
Perf. (%) -22.27%
Target price 95.150
Change
Ends at 11.03.25

Merck & Co., Inc. (NYSE: MRK) was downgraded by analysts at Societe Generale from a "hold" rating to a "sell" rating. They now have a $104.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

In the thread Trading Merck & Co. Inc.
Prediction Sell
Perf. (%) -22.27%
Target price 95.150
Change
Ends at 11.03.25

Die von Societe_Generale gewählte maximale Laufzeit wurde überschritten